Organovo Holdings ( (ONVO) ) has released a notification of late filing.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Organovo Holdings, Inc., a company involved in the field of 3D bioprinting, has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending December 31, 2024. The delay is primarily attributed to the company’s transition to a new Chief Financial Officer, which has necessitated additional time to gather the required information for the report. Despite the delay, the company plans to submit the report within five calendar days following the original due date, ensuring minimal disruption. Importantly, Organovo Holdings does not anticipate any significant changes in its financial results for the reported period, cushioning investor concerns. The notification was signed by Keith Murphy, the company’s Executive Chairman, emphasizing its commitment to maintaining compliance and transparency.
More about Organovo Holdings
YTD Price Performance: -14.09%
Average Trading Volume: 213,580
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.81M
Find detailed analytics on ONVO stock on TipRanks’ Stock Analysis page.